| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 491.086 | 460.874 | 520.869 | 493.033 | 509.547 | 573.145 | 587.228 | 742.791 | 788.292 | 788.500 |
| Total Income - EUR | 492.223 | 462.093 | 521.411 | 493.789 | 509.953 | 575.958 | 588.158 | 743.861 | 790.624 | 789.370 |
| Total Expenses - EUR | 487.477 | 449.220 | 508.236 | 464.205 | 467.970 | 521.114 | 549.953 | 676.451 | 737.972 | 743.213 |
| Gross Profit/Loss - EUR | 4.746 | 12.873 | 13.175 | 29.584 | 41.983 | 54.843 | 38.205 | 67.410 | 52.652 | 46.157 |
| Net Profit/Loss - EUR | 2.607 | 9.856 | 9.330 | 24.046 | 34.473 | 45.303 | 31.157 | 54.871 | 42.040 | 36.874 |
| Employees | 5 | 5 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 5 |
Check the financial reports for the company - Oxyfarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 107.286 | 95.590 | 84.615 | 72.705 | 65.802 | 106.692 | 90.421 | 79.764 | 69.029 | 58.164 |
| Current Assets | 118.062 | 110.693 | 108.313 | 151.459 | 157.870 | 167.932 | 179.305 | 247.352 | 240.131 | 257.011 |
| Inventories | 48.537 | 49.608 | 32.783 | 28.409 | 36.421 | 47.424 | 42.370 | 57.310 | 72.751 | 106.618 |
| Receivables | 50.021 | 33.595 | 63.540 | 84.903 | 73.809 | 93.341 | 99.642 | 139.495 | 135.062 | 96.229 |
| Cash | 19.504 | 27.490 | 11.990 | 38.147 | 47.640 | 27.167 | 37.293 | 50.548 | 32.318 | 54.164 |
| Shareholders Funds | 149.389 | 117.546 | 117.974 | 129.539 | 152.631 | 179.808 | 194.827 | 202.064 | 230.746 | 257.808 |
| Social Capital | 90 | 89 | 9.938 | 9.756 | 9.567 | 9.386 | 9.178 | 9.206 | 9.178 | 9.127 |
| Debts | 75.959 | 88.736 | 74.972 | 94.643 | 71.041 | 94.815 | 74.900 | 125.052 | 78.414 | 57.367 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Oxyfarm Srl